Related Experiment Videos

Diabetes-induced decrease in the mRNA coding for sarcoplasmic reticulum Ca(2+)-ATPase in adult rat cardiomyocytes

M Russ1, H Reinauer, J Eckel

  • 1Laboratory of Molecular Cardiology, Diabetes Research Institute, Düsseldorf, Federal Republic of Germany.

Insights

Diabetic and obese rat hearts show reduced sarcoplasmic reticulum Ca(2+)-ATPase mRNA levels. This decrease in calcium pump gene expression may contribute to impaired heart relaxation in diabetes.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • Endocrinology

Background:

  • Diabetes and obesity are associated with cardiac dysfunction.
  • Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is crucial for cardiac muscle relaxation.
  • Alterations in SERCA gene expression may underlie diabetic cardiomyopathy.

Purpose of the Study:

  • To investigate the mRNA levels of sarcoplasmic reticulum Ca(2+)-ATPase in two distinct models of cardiac disease: streptozotocin-induced diabetes and genetic obesity.
  • To correlate changes in Ca(2+)-ATPase mRNA with potential functional deficits in the diabetic heart.

Main Methods:

  • Isolation of ventricular myocytes from streptozotocin-diabetic rats and genetically obese (fa/fa) rats.
  • Quantification of sarcoplasmic reticulum Ca(2+)-ATPase mRNA using Northern blotting techniques.
  • Comparison of mRNA levels between diseased and control animal groups.

Main Results:

  • A single transcript for sarcoplasmic reticulum Ca(2+)-ATPase (4.12 kb) was detected in all groups.
  • Insulin-deficient (diabetic) rats exhibited a significant 51% decrease in Ca(2+)-ATPase mRNA levels compared to normal rats.
  • Genetically obese rats showed a modest 23% reduction in Ca(2+)-ATPase mRNA content relative to lean controls.

Conclusions:

  • Reduced mRNA expression of the sarcoplasmic reticulum Ca(2+)-ATPase is evident in both diabetic and obese rat hearts.
  • These molecular changes may partially explain the observed delayed diastolic relaxation in the diabetic heart.
  • Further research is warranted to explore the therapeutic potential of targeting SERCA expression in metabolic cardiomyopathies.

Related Concept Videos